The haemodynamic response to propranolol in cirrhosis with arterial hypertension: A comparative analysis with normotensive cirrhotic patients

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 1, 2010, Pages 105-112

  Sharma, P ^a   Kumar, A ^a,c   Jha, S ^b   Mishra, S R ^b   Sharma, B C ^b   Sarin, S K ^a,b,c  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b G B PANT HOSPITAL   (India)

^c JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PROPRANOLOL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; CREATININE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG RESPONSE; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; HEART RATE; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRESSURE GRADIENT; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; SYSTEMIC VASCULAR RESISTANCE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROPRANOLOL; RETROSPECTIVE STUDIES;

EID: 77953186249     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04308.x     Document Type: Article

References (31)

1. Henriksen JH, Moller S. Liver cirrhosis and arterial hypertension. World J Gastroenterol 2006 12 : 678 685.
2. Henriksen JH, Fuglsang S, Bendtsen F, Møller S. Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics. Gut 2006 55 : 380 387.
3. Loyke HF, Cutarelli R. An evaluation of hypertension and liver disease in an alcoholic service. Am J Med Sci 1960 240 : 346 348.
4. Spatt SD, Rosenblatt P. The incidence of hypertension in portal cirrhosis: a study of 80 necropsied cases of portal cirrhosis. Ann Int Med 1949 31 : 479 483.
5. Loyke HF. The relationship of cirrhosis of the liver to hypertension: a study of 504 cases of cirrhosis of the liver. Am J Med Sci 1955 230 : 627 632.
6. Loyke HF. Reduction of hypertension after liver disease. Arch Intern Med 1962 110 : 45 9.
7. Lopez C, Jimenez W, Arroyo V, et al. Temporal relationship between the decrease in arterial pressure and sodium retention in conscious spontaneously hypertensive rats with carbon tetra-chloride induced cirrhosis. Hepatology 1991 13 : 585 589.
8. Veglio F, Pinna G, Melchio R, et al. Hormonal aspects of the relation of liver cirrhosis to essential hypertension. Clin Exp Hypertens [A] 1992 14 : 889 903.
9. Schwartz DT. The relation of cirrhosis of the liver to renal hypertension. A review of 639 autopsied cases. Ann Intern Med 1967 66 : 862 869.
10. Arroyo V, Ginbs P, Jimenez W, Rod J. Ascites, renal failure, and electrolyte disorders in cirrhosis. Pathogenesis, diagnosis, and treatment. In : McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology.
11. Gentilini P, Lafti G, La Villa G, et al. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 1997 92 : 66 72.
12. de Franchis R. Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005 43 : 167 176.
13. Lebrec D, Nouel O, Bernuau J, et al. Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet 1981 1 : 920 921.
14. Lebrec D, Hillon P, Munoz C, et al. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982 2 : 523 527. (Pubitemid 13173931)
15. Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995 346 : 1056 1059.
16. Villanueva C, Balanzo J, Novella MT, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996 334 : 1624 1629.
17. Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000 32 : 930 934.
18. Krousel-Wood MA, Muntner P, He J, et al. Primary prevention of essential hypertension. Med Clin North Am 2004 88 : 223 238.
19. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004 39 : 280 282.
20. Hoeper MM, Maier R, Tongers J, et al. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 1999 160 : 535 541.
21. Groszmann R. Vasodilatation and hyperdynamic circulatory state in chronic liver disease. In : Bosch J, Groszmann R, eds. Portal Hypertension. Pathophysiology and Treatment.
22. Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988 8 : 1151 1157.
23. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 1997 30 : 1267 1273.
24. Palatini P, Dorigatti F, Zaetta V, et al. Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study. J Hypertens 2006 24 : 1873 1880.
25. Inoue T, Iseki K, Iseki C, Kinjo K, Ohya Y, Takishita S. Higher heart rate predicts the risk of developing hypertension in a normotensive screened cohort. Circ J 2007 71 : 1755 1760.
26. Møller S, Wiinberg N, Hernriksen JH. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995 22 : 88 95.
27. Møller S, Bendtsen F, Henriksen JH. Vasoactive substances in the circulatory dysfunction of cirrhosis. Scand J Clin Lab Invest 2001 61 : 421 499.
28. Gatta A, Sacerdoti D, Merkel C, Milani L, Battaglia G, Zuin R. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension. Am Heart J 1984 108 : 1167 1172.
29. Bañares R, Moitinho E, Matilla A, et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology 2002 36 : 1367 1373.
30. González-Abraldes J, Albillos A, Bañares R, et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 2001 121 : 382 388.
31. Mastai R, Bosch J, Bruix J, Navasa M, Kravetz D, Rodés J. Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology 1989 10 : 269 272.